Genomics Market

Genomics Market Overview

The global genomics market size, valued at USD 38.77 billion in 2024, is expected to reach USD 46.06 billion in 2025 and USD 186.64 billion by 2035, representing a compounded annual growth rate (CAGR) of 15.0% during the forecast period.

To learn more about this report, request a free sample copy

Genomics refers to the scientific field that leverages DNA-based technologies and computation tools to study an individual gene profile. The study of genomics includes numerous molecular based approaches including cloning, sequencing and recombination to understand the function of genes and underlying causes of diseases. With a transformative shift towards personalized therapeutics, there is a sudden increase in the adoption of genomics across healthcare and pharmaceutical industry.

It is important to highlight here that earlier, traditional one-size fit approaches have been implemented to treat patients with different diseases including chronic conditions and cancer. However, it is important to understand that drug effectiveness is not merely about receptor binding; instead, it involves absorption, distribution, metabolism and excretion. Moreover, each individual has its own unique genome profile, hence a common approach may not be sufficient to meet the unmet medical requirement of a patient.

In order to make treatment and drug discovery more effective, the world of omics (such as single-cell omics) has significantly gained momentum. Additionally, the availability of advanced technologies, such as polymerase chain reactions, CRISPR technologies, genome editing technologies, DNA read, write and edit, researchers can collect information about gene structure, function and their pivotal role in diseases. With detailed information about genetic makeup, researchers can develop personalized therapies, targeted therapies and increase their understanding of disease mechanism as well as drug response.

Driven by the growing awareness of genomics benefits in drug development, several industrial players are increasing their strategic initiatives to develop innovative technologies. However, their primary focus in on the development of high-throughput sequencing technologies such as next generation sequencing and platforms. For instance, in September 2024, SOPHiA GENETICS (a cloud-native healthcare technology provider) launched next generation SOPHiA DDM™ platform that offer more efficient evaluation and storage of large amount of genome data.

In addition to technological innovations, several genomic industrial players are forging collaborations and partnerships to broaden their research on genomics. For instance, in January 2025, Variant Bio entered into a strategic deal with Novo Nordisk for the use of genetic research in order to treat patients suffering from metabolic diseases. As stated by David Moller (Chief Scientist, Variant Bio) “Most research on the role of genetics in disease has focused on people with European ancestry. Variant is partnering with Indigenous peoples worldwide to build more representative data sets. We hope that a deeper understanding of the relationships between genetic variation and metabolic traits will yield novel targets and ultimately lead to better and more diverse treatment options for people around the globe.”

As more market players continue to increase their efforts, we believe that genomics market growth will continue at a steady rate during the forecast period.

Genomics Market Segmentation Insights

The market report provides comprehensive information on the industrial players who are presently active across various segments of the growing genomics industry.

Genomics Market: Report Attributes / Market Segmentation

Key Report Attributes	Details
Historical Trend	Since 2019
Forecast Period	Till 2035
Current Market Size	$ 46.06 Billion
Market Size 2035	$ 186.64 Billion
CAGR (Till 2035)	15.0%
Type of Deliverable	Products (Instruments / Systems / Software, and Consumables & Reagents) Services (NGS-based Services, Core Genomics Services, Biomarker Translation Services, Computational Services and Other Services)
Type of Technology	Sequencing Polymerase Chain Reaction Flow Cytometry Microarrays Other Technologies
Type of Process	Library Preparation Data Analysis
Type of Study	Functional Genomics (Transfection, Real-Time PCR, RNA Interference, Mutational Analysis, SNP Analysis and Microarray Analysis) Epigenomics (Bisulfite Sequencing, Chromatin Immunoprecipitation (ChIP & ChIP-Seq), Methylated DNA Immunoprecipitation (MeDIP), High-Resolution Melt (HRM), Chromatin Accessibility Assays and Microarray Analysis) Pathway Analysis (Bead-Based Analysis, Microarray Analysis, Real-time PCR and Proteomics Tools (2-D PAGE; yeast 2-hybrid studies) Biomarker Discovery (Mass Spectrometry, Real-Time PCR, Microarray Analysis, Statistical Analysis, Bioinformatics and DNA Sequencing and Others)
Type of Application Area	Diagnostics Drug Discovery and Development Precision Medicine Agriculture & Animal Research Other Applications
End User	Clinical Research Institutes Academic & Government Institutes Hospitals & Clinics Pharmaceutical & Biotechnology Companies Other End Users
Geographical Regions	North America (US, Canada and Mexico) Europe (France, Germany, Italy, Spain, UK and Rest of Europe) Asia-Pacific (China, India, Japan, South Korea, Australia, Russia, Thailand, Malaysia, Indonesia and Rest of the Asia-Pacific) Midde East and North Africa (Egypt, Saudi Arabia and UAE) Latin America (Argentina and Brazil)
Key Companies Profiled	23andMe Agilent Technologies Bio-Rad Laboratories BGI Genomics Color Genomics Danaher Eppendorf Eurofins Scientific (Eurofins USA Genomic Services) GE HealthCare Illumina Myriad Genetics Oxford Nanopore Technologies Pacific Biosciences QIAGEN Quest Diagnostics Roche Thermo Fisher Scientific (A complete list of companies captured is available in the report)
PowerPoint Presentation (Complimentary)	Available
Customization Scope	15% Free Customization
Excel Data Packs (Complimentary)	Available

One of the key objectives of the genomics market report was to estimate the current market size, opportunity and the market growth potential, over the forecast period, till 2035. We have provided informed estimates on the likely evolution of the market for the forecast period.

The genomics market analysis also features the likely distribution of the current and forecasted opportunity within the market across various segments, such as type of deliverable (products (instruments / systems / software, and consumables & reagents) and services (NGS-based services, core genomics services, biomarker translation services, computational services and other services)), type of technology (sequencing, polymerase chain reaction, flow cytometry, microarrays and other technologies), type of process (library preparation and data analysis), type of study (functional genomics (transfection, real-time PCR, RNA interference, mutational analysis, SNP analysis and microarray analysis), epigenomics (bisulfite sequencing, chromatin immunoprecipitation (ChIP & ChIP-Seq), methylated DNA immunoprecipitation (MeDIP), high-resolution melt (HRM), chromatin accessibility assays and microarray analysis), pathway analysis (bead-based analysis, microarray analysis, real-time PCR and proteomics tools (2-D PAGE; yeast 2-hybrid studies)), biomarker discovery (mass spectrometry, real-time PCR, microarray analysis, statistical analysis, bioinformatics and DNA sequencing and others)), type of application area (diagnostics, drug discovery and development, precision medicine, agriculture & animal research and other applications), end user (clinical research institutes, academic & government institutes, hospitals & clinics, and pharmaceutical & biotechnology companies, and other end users), geographical region (North America, Europe, Asia-Pacific, Middle East and North Africa, and Latin America) and leading players.

In order to account for future uncertainties associated with some of the key parameters and to add robustness to our model, we have provided three market forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of industry’s evolution.

All actual figures have been sourced and analyzed from publicly available information forums and primary research discussions. The financial figures mentioned in this market report are in USD, unless otherwise specified.

Genomics Market Share Insights

Market Share by Type of Deliverable

Based on the type of deliverable, the global genomics market is distributed into products (instruments / systems / software, and consumables & reagents) and services (NGS-based services, core genomics services, biomarker translation services, computational services and other services). It is worth mentioning here that product segment accounts for the largest share (over 70%) of the market. This is primarily due to the fact that genome study requires instruments / system / software and consumables & reagents on a large scale. Thus, increasing demand for products in clinical trials, academic research and hospitals are likely to be the key reason for highest share.

However, in the long run, services segment will show lucrative growth potential and is expected to grow at a higher CAGR during the forecast period. This can be attributed to the growing shift towards outsourcing of sequencing services (including next generation sequencing services) due to high cost of products and requirement of skilled labor forces.

Market Share by Type of Technology

The global genomics market size is distributed across different type of technologies, such as sequencing, polymerase chain reaction, flow cytometry, microarrays and other technologies. According to our projection, currently polymerase chain reaction accounts for the highest share of the market. This can be attributed to the growing usage of PCR technology for genome studies, amplification and diagnoses of diseases.

However, in the long run, sequencing and microarrays are likely to show lucrative growth potential, expecting to grow at a higher CAGR during the forecast period. This is primarily due to the expanding usage of next generation sequencing technologies to understand genome profiles.

Market Share by Type of Process

On the basis of process type, the global market is distributed across library preparation and data analysis. It is worth mentioning here that data analysis accounts for the highest genomics market size. This can be attributed to the fact that genomics is widely used for a wide range of tasks, such as data interpretation, variant calling and quality control. The information collected from sequenced data helps to enhance understanding of disease mechanism and allows researchers to develop personalized therapeutics. Driven by its growing usage, this segment will continue to expand at a higher CAGR during the forecast period.

Market Share by Type of Study

This segment highlights the distribution of global genomics industry opportunity across different application areas, such as functional genomics (transfection, real-time PCR, RNA interference, mutational analysis, single nucleotide polymorphism (SNP) genotyping analysis and microarray analysis), epigenomics (bisulfite sequencing, chromatin immunoprecipitation (ChIP & ChIP-Seq), methylated DNA immunoprecipitation (MeDIP), high-resolution melt (HRM), chromatin accessibility assays and microarray analysis), pathway analysis (bead-based analysis, microarray analysis, real-time PCR and proteomics tools (2-D PAGE; yeast 2-hybrid studies)) and biomarker discovery (mass spectrometry, real-time PCR, microarray analysis, statistical analysis, bioinformatics and DNA sequencing, and others).

Among these, functional genomics segment occupies the largest genomics market share (nearly 35%). This dominance is due to the increasing research studies to understand the specific genome expression of disease condition. Furthermore, functional genomics is playing a significant role in the development of cancer therapies and gene therapy. However, it is worth noting that pathway analysis is expected to grow at a higher CAGR during the forecast period. This is likely to be the result of increasing usage of pathway-based analysis to develop targeted therapies and disease diagnosis.

Market Share by Type of Application Area

Based on the application area, the global genomics market size is distributed across, diagnostics, drug discovery and development, precision medicine, agriculture & animal research and other applications. According to our projection, currently diagnostics segment accounts for the largest share of the market. This can be attributed to the growing usage of next generation sequencing technologies for disease diagnostics and understanding disease mechanism. Additionally, the rising prevalence of chronic diseases is expected to accelerate the adoption of genome sequencing during the projected period.

However, in the long run, drug discovery and development is expected to grow at a higher CAGR during the forecast period. This is primarily due to the accelerated adoption of next generation sequencing, whole genome sequencing and gene editing technologies for identification of drug targets and clinical studies.

Market Share by End User

Based on the end user, the global market is segmented into clinical research institutes, academic & government institutes, hospitals & clinics, and pharmaceutical & biotechnology companies, and other end users. According to our market study, pharmaceutical & biotechnology genomics companies segment holds the highest genomics market share (nearly 55%). This can be attributed to the rising usage of genomics for understanding disease mechanism, drug discovery and development. Furthermore, the growing adoption of metagenomics and spatial genomics for drug discovery has further contributed to the highest share.

However, in the future hospitals & clinics segment is likely to grow at a higher CAGR during the forecast period. This is primarily due to the increasing adoption of genomics to understand disease progression and diagnostics in hospitals.

Market Share by Geographical Regions

According to our genomics market analysis, currently North America accounts for the largest share (nearly 45%) of the market. This is likely to be the result of expanding use of genomics for different drug research and diagnostics purpose. Additionally, the increasing research initiatives by industrial players to expand utility of genomics across different medical applications. For instance, in July 2024, Thermo Fisher Scientific partnered with National Cancer Institute to accelerate research on advanced treatments for Acute Myeloid Leukemia and Myelodysplastic Syndrome. Under this partnership, the institute will utilize Thermo Fisher’s next generation sequencing technology to test samples for bone marrow and blood for certain genetic biomarkers.

However, in Asia-Pacific, the market for genomics is expected to register a higher CAGR during the forecast period. This can be attributed to the increasing incidence of chronic diseases and cancer. Furthermore, high demand for precision medicine and increasing human genome projects in Asian countries to understand disease progression and drug development is anticipated to be a key reason for lucrative growth potentials. For instance, in January 2025, Dr Jitendra Singh (Union Minister of State (Independent Charge) for Science and Technology, India) announced launched of Indian Genomic Data Set & IBDC Portals to empower global research and India’s genomic revolution. With this strategic initiative Indian will no longer required to rely on foreign genomic data driven by the launch of ‘Framework for Exchange of Data Protocols (FeED)’ and the Indian Biological Data Centre (IBDC) Portals, which is likely to sequence 10,000 whole genome samples accessible to researchers across India and the globe.

Genomics Market Dynamics Insights

The “Genomics Market: Industry Trends and Global Forecasts, till 2035” research report features an extensive study of the focus on competitive landscape of strategic initiatives, emerging mega trends, big pharma initiatives, company profiles and key drivers and restraints. The market report highlights the efforts of several stakeholders engaged in this rapidly evolving segment of the life sciences industry. Key takeaways of the market data analysis are briefly discussed below.

Genomics Market Competitive Landscape

Notably, genomics industry is moderately competitive featuring the presence of well-established and new entrants with required expertise. In order to leverage the competitive edge, various industrial players are aiming for bringing advanced technologies that truly transform genome analysis with a real-time approach. Moreover, the focus will remain on delivering innovative kits that facilitate genome analysis with an end-to-end approach. For instance, in March 2024, BioSkryb Genomics steering announced the commercial launch of its latest ResolveDNA Whole Genome and ResolveOME Whole Genome and Transcriptome Single-Cell Core kits in the US market. These kits use primary template-directed amplification within end-to-end kitted workflow that offer library preparation reagents, amplification, sequencing adapters and BaseJumper® bioinformatics platform to gain better insight in human genomes.

As more market players continue to facilitate technological innovations, the market for genomics will remain competitive throughout the projected period.

Market Drivers: Rising Prevalence of Cancer and Adoption of Omics to Understand Disease Mechanism

Some of the potential market drivers that are anticipated to drive the genomics market growth includes rising prevalence of cancer and growing adoption of next generation sequencing in cancer research. As per the cancer statistics published by American Cancer Society in 2025, nearly 2,041,910 new cases of cancer has been detected and 6,18,120 cancer death are projected to occur in the US. This, rising prevalence of cancer has necessitated the demand for advanced genome analysis technologies for cancer research and personalized therapeutic drugs. In addition to the rising prevalence of cancer, the growing adoption of omics to broaden research on disease understanding and personalized treatment development will drive market growth.

Market Challenges: High Cost, Technological Complexity and the Requirement of Trained Professionals

Genomics study involves gene editing, identification, amplification, multiplexing and sequencing. The entire process is highly sensitive and complex in nature that requires innovative instruments, such as PCR technology, microarray equipment, analyzers, centrifuges and liquid handling equipment. These instruments require precise handling due to high sensitivity and technological complexity. Thus, technological complexity may seem like a significant barrier in adopting genome analyzers on a large scale.

Furthermore, high cost of sequencing and installation may impede the adoption rate specifically by small pharmaceutical players. Additionally, there is a lack of trained professionals which further impedes genomics market growth during the forecast period.

Genomics Market Trends: Increasing Applications in Rare Disorder, Artificial Intelligence and Single Cell Genomics

Despite the challenges, the market for genomics is experiencing an upward trajectory driven by the expanding utilization of genomics in understand rare disorders. Advanced technologies such as next generation sequencing helps to understand the human genome quickly which makes it an unprecedented tool for diagnosing rare disorders with higher precision. This expanding usage across different medical applications, specifically in rare disorders offer enormous opportunities for industrial leaders to drive innovation in this field.

In addition to growing applications, the integration of artificial intelligence and machine learning to accelerate the data analysis for disease diagnostics and drug discovery has further opened pathway for industrial players. Furthermore, the increasing adoption of single cell sequencing to study function of single gene, identify enzymes and analyze antibiotic resistance development is the key genomics market growth factor that is anticipated to drive the industry during the forecast period.

Genomics Market Size Analysis

Currently, the global genomics market is expected to be valued at USD 46.06 billion in 2025 and is poised to reach USD 186.64 billion by 2035. Driven by the rising prevalence of cancer and paradigm shift towards broad spectrum genomics to discover biomarkers-targeted drugs and personalized therapeutics has caught significant attention of industrial players. Additionally, the increasing adoption of proteomics, genomics and metabolomics are the key growth drivers for the market.

It is important to highlight here that the industrial players are increasing strategic partnerships and collaborations to drive innovations in this field. For instance, in September 2024, Cancer Research Horizons (Cancer Research UK) and AstraZeneca forged a five-year renewal of the Functional Genomics Centre to advance drug discovery with genome-altering technologies such as CRISPR gene editing. As stated by Douglas Ross-Thriepland, Lead of the Functional Genomics Centre, AstraZeneca “CRISPR gene editing is an incredibly exciting tool for target discovery. It helps us tap into previously unknown biology and advances our understanding of cancer resistance mechanisms. By combining it with genetic screens, cancer models and computational approaches, our aim is to accelerate the development of new medicines for patients who need them the most.”

Notably, the market will remain progressive during the forecast period and is likely to grow at a CAGR of 15.0%.

Leading Companies in Genomics Market

Examples of top companies in genomics industry (which have also been captured in this report) include 23andMe, Agilent Technologies, Bio-Rad Laboratories, BGI Genomics, Color Genomics, Danaher, Eppendorf, Eurofins Scientific (Eurofins USA Genomic Services), GE HealthCare, Illumina, Myriad Genetics, Oxford Nanopore Technologies, Pacific Biosciences of California, QIAGEN, Quest Diagnostics, Roche and Thermo Fisher Scientific.

Genomics Market Report Coverage

The market report presents an in-depth analysis, highlighting the capabilities of various companies engaged in this domain across different segments. Amongst other elements, the market report includes:

• A preface providing an introduction to the full report, Genomics Market, 2019-2024 (Historical Trends), and Future Forecast till 2035 (Forecasted Estimates).
• An outline of the systematic research methodology adopted to conduct the study on the genomics industry, providing insights on the various assumptions, methodologies, and quality control measures employed to ensure the accuracy and reliability of our findings.
• An overview of economic factors that impact the overall genomics market, including historical trends, currency fluctuation, foreign exchange impact, recession, and inflation measurement.
• An executive summary of the insights captured during our research. It offers a high-level view of the current state of the market and its evolution in the mid-and long-term.
• A detailed assessment of the genomics market landscape is based on several relevant parameters, including years of experience, company size, headquarters location, and ownership structure.
• Elaborated profiles of prominent players engaged in offering genomics products, featuring information on their year of establishment, location of headquarters, company size, company mission, company footprint, management team, contact details, financial information, operating business segments, product and service portfolio, recent developments, and an informed future outlook.
• A discussion on affiliated trends, key drivers, and challenges under a SWOT framework, which is likely to impact the industry's evolution, along with a Harvey ball analysis, highlighting the relative effect of each SWOT parameter on the overall genomics industry.
• A market impact analysis features a discussion on the factors that can impact the genomics market growth.
• A detailed estimate of the current market size and the future growth potential of the market over the next decade. Based on multiple parameters, we have provided an informed estimate of the market's evolution during the forecast period till 2035. The report also features the likely distribution of the current and forecasted opportunities within the genomics industry. Further, in order to account for future uncertainties and to add robustness to our model, we have provided three forecast scenarios, namely conservative, base, and optimistic scenarios, representing different tracks of the industry’s growth.
• Detailed projections of the current and future genomics market across various types of deliverable including products (instruments / systems / software and consumables & reagents) and services (NGS-based services, core genomics services, biomarker translation services, computational services and other services).
• Detailed projections of the current and future genomics industry opportunity across different types of technique, including sequencing, polymerase chain reaction, flow cytometry, microarrays and other technologies.
• Detailed projections of the current and future genomics market across various types of process, including library preparation and data analysis.
• Detailed projections of the current and future opportunity for genomics companies across different types of study, including functional genomics (transfection, real-time PCR, RNA interference, mutational analysis, SNP analysis and microarray analysis), epigenomics (bisulfite sequencing, chromatin immunoprecipitation (ChIP & ChIP-Seq), methylated DNA immunoprecipitation (MeDIP), high-resolution melt (HRM), chromatin accessibility assays and microarray analysis), pathway analysis (bead-based analysis, microarray analysis, real-time PCR and proteomics tools (2-D PAGE; yeast 2-hybrid studies)) and biomarker discovery (mass spectrometry, real-time PCR, microarray analysis, statistical analysis, bioinformatics and DNA sequencing and others)).
• Detailed projections of the current and future genomics market across different types of application area, including diagnostics, drug discovery and development, precision medicine, agriculture & animal research and other applications.
• Detailed projections of the current and future genomics industry across different types of end user, including clinical research institutes, academic & government institutes, hospitals & clinics and pharmaceutical & biotechnology companies and other end users.
• Detailed projections of the current and future market for genomics across various key geographical regions, such as North America (US, Canada and Mexico), Europe (France, Germany, Italy, Spain, UK and rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Australia, Russia, Thailand, Malaysia, Indonesia and rest of the Asia-Pacific), Middle East and North Africa (Egypt, Saudi Arabia and UAE) and Latin America (Argentina and Brazil).

Recent Developments in Genomics Market

Several recent developments have taken place in the field of genomics. We have outlined some of these recent initiatives below.

• In January 2025, BioSkryb Genomics (pioneer in single cell genomics and ultra-low input multiomics) announced the launch of ResolveSEQ MRD (advanced genomic sequencing services) that offers paired single cell genome, transcriptome characterization and integrates flow cytometry protocols for discovering therapeutic signatures and prognostics in MRD cells for hematologic malignancies.
• In November 2024, Department of Biotechnology and Biotechnology Research and Innovation Council, India introduced the initiative of “One Day One Genome” to showcase massive microbial potential of India.
• In October 2024, Illumina (DNA sequencing and array-based technologies provider) presented latest updates on various innovations in whole-genome sequencing, proteomics, and single-cell technology at the American Society of Human Genetics (ASHG) Annual Meeting in Denver.
• In May 2024, SOPHiA GENETICS entered into strategic collaboration with Microsoft and NVIDIA to harness latter companies expertise in technology and genomics to bring a streamlined and scalable whole genome sequencing (WGS) analytical solution to healthcare institutions.